Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (year values)

2019 2020 2021 2022 2023   LTM ?
Debt/EBITDA 1.31 1.75 2.03 0.98 -1.07   10.1
Changes by years, y/y, % +4% +34% +16% -52% -209%    

Alnylam Pharmaceuticals. Debt/EBITDA

Alnylam Pharmaceuticals. Debt/EBITDA, changes, %

Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Debt/EBITDA 2.86 -0.79 -1.60 0.74 10.1   10.1
Changes by years, y/y, % +128% -165% -255% -20% +251%    
Changes by quarters, q/q, % +208% -127% +103% -146% +1 253%    

Alnylam Pharmaceuticals. Debt/EBITDA

Alnylam Pharmaceuticals. Debt/EBITDA, changes, y/y, %

Alnylam Pharmaceuticals. Debt/EBITDA, changes, q/q, %